Aspire Medtech

Aspire logo

Medtech Startups Prepare for Investor Engagement with Aspire

Aspire Medtech is a five-week in-depth, hybrid program that prepares startups for investor engagement. Investor-mentors work one-on-one with startups to simulate due diligence conversations and integrate feedback into deal room materials in real-time. This program aims to prepare startups to raise equity investment.

Applications will open in June 2024. Join the waitlist to receive updates when they become available.


Aspire Medtech 2022 cohort group photo

Read about our 2023 Aspire Medtech cohort!


Why Apply?

Spend one-on-one time with investor-mentors
You will work with high-caliber investor-mentors throughout the program who have experience investing or partnering with startups like yours.

Vet your fundraising strategy
Startups will leave with a clear articulation of their investment needs, including the investment ask and planned milestones for the round. Take part in a mock board meeting to prepare yourself for fundraising and investor conversations.

Due Diligence Deal Room
Spend time creating and refining deal room materials
to use during the fundraising process. Invest your time and energy into a work product for a deal room discussion, not a demo day pitch.

Stress-test your startup
Work through real-world disaster scenarios with your team
to discover how to best prepare for the unexpected.

Collaborate and network
Connect with fellow founders and leverage the VentureWell investor network after the program ends.

Symbols with legend Vetted Mentors + Network + Clear Milestones & Ask + Due Diligence Deal Room + Stress Tests


Meet the Aspire Medtech 2023 Investor-Mentor Team

 

Sue Bevan BaggottSue Baggott headshot

Angel Investor, Queen City Angels

 

 

Elaine Bolle headshotElaine Bolle

Angel Investor, RTP Angel Fund and Portfolia Active Aging and Longevity Fund

 

 

Diane Bouis headshotDiane Bouis

Program Director, U.S. Accelerator Program, MedTech Innovator

 

 

Shubha K. Chakravarthy headshotShubha K. Chakravarthy

Founder, Achiiv

 

 

Marcia Dawood headshotMarcia Dawood, Mentor-in-Residence

Angel Investor, Angel Capital Association and Mindshift Capital

 

 

Margarita HernandezMargarita Hernandez headshot

Vice President of Entrepreneurial Services, Ann Arbor SPARK

 

 

Dayo Idowu headshotDayo Idowu

Business Development Manager, QTS Medical Device Outsourcing; Business Development Lead, Groove Capital

 

 

Deborah Livneh headshotDeborah Livneh

Executive Director, WECAN Investors

 

 

Dave Morin headshotDave Morin

Founder and Managing Mentor, Care Technology Advisors

 

 

Eddie Patton Jr.Eddie Patton Jr. headshot

General Partner, Prosalus Capital Partners

Entrepreneur and Neurologist

 

Marquicia Pierce headshotMarquicia Pierce

Founder and Principal Consultant, Ruby Leaf Media

 

 

Denise Saltojanes headshotDenise Saltojanes

Angel Investor, Golden Seeds and NuFund Venture Group

 

 

Jonathan SeltzerJonathan Seltzer headshot

Angel Investor, NuFund Venture Group

 

 


Meet the Aspire Medtech 2023 Entrepreneur-in-Residence Team

 

Patrick Beattie headshotPatrick Beattie

Former CEO and Co-Founder, Redbird

 

 

Katie Solley headshotKatie Solley

Co-Founder and CEO, Eyedea Medical

 

 


Does Your Startup Qualify?

For each cohort, VentureWell selects 10-15 dedicated science- and engineering-based startups from across the nation that are launching high-impact inventions. Startups must be committed and competitive!

  • Team identified and startup formed. First-time founders with management team and key roles identified—no one-person teams. Incorporated as a legal entity by the beginning of the program.
  • High-impact inventions. Innovation has a clear positive impact, solves a real problem felt by customers, and has a compelling value proposition.
  • Early market validation. Validated customer segments and initial evidence of product-market fit. Articulation of economic value proposition and evidence of customer buy-in.
  • Intellectual property. Provisional patent(s) filed and assigned to the company or evidence of a clear pathway to the license.
  • Beyond proof of concept. Initial prototype developed and pilot studies/field trials underway.
  • Actively fundraising. Company has raised at least $25K (grants or equity) and is preparing for a round of equity investment within 12 months.

The Aspire Impact

  • 177 startups have participated in Aspire since 2015.
  • These teams have raised over $430M in follow-on funding since taking part in Aspire.
  • Our startups have an 81% venture persistence rate.

Questions? Contact Patrick Beattie.


The Fall 2023 Aspire Medtech program is offered in partnership with our generous sponsors, Techtown Detroit, MedHealth, Cooley LLP, and The Lemelson Foundation.

Aspire Medtech 2023 sponsor logos: The Lemelson Foundation, MedHealth, Techtown Detroit, Cooley LLP, in2being LLC

By continuing to use the site, you agree to the use of cookies. Read More